Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
More trials, same controls. We design, build and validate your statistical computing environment in your cloud: validated R and Python packages reach statisticians in days, historical SAS still runs, and the GxP work is carried for you.
A filing or a pivotal readout within 24 months, and the environment that has to carry it was last updated years ago, with a long IT queue in front of every change. This is the trigger behind every full-environment engagement we have signed.
Five global sponsors presented the replacement or refactoring of a home-grown SCE at PHUSE between 2022 and 2026. Their words: outdated technology, retiring engineers, a shortage of skilled people, and extensive revalidation for every enhancement. At mid-size the same story reads: we have outgrown our SAS environment, and there is no quick fix.
The third reason is sourcing. Biometrics runs on a CRO's or a vendor's environment and licences, nobody can independently verify when a QC report was actually run, and every insourcing or outsourcing decision is constrained by whose environment the study lives in. If one of these three is yours, the timing is now.
Book a Scoping Call
SPEED
New packages are assessed against a written risk procedure and released on a cadence your studies can plan around, instead of behind a six-to-nine-month queue. Statisticians stop waiting and stop working around the environment, which is what lets a growing programme add trials without adding a queue.
COMPLIANCE
Evidence is produced as the environment runs, not assembled before every audit. A new package or a rebuilt container does not wait for a validation cycle, and your QA gets records they can verify and rerun.
OWNERSHIP
Built in your AWS or Azure, on your identity and storage, with the code, the data and the infrastructure yours. It stays yours if we leave.
IT CAPACITY
We integrate with what you run rather than replace it, and we can operate the environment for you: package assessment, validation refreshes, upgrades and L2/L3 support. Your platform team keeps its roadmap.
CONTINUITY
R, Python and SAS side by side, on SAS or on Altair SLC, so an auditor's request to rerun a historical analysis is answered from the same environment as today's work.
HEADROOM
The environment is designed so that AI-assisted programming workflows can run inside the validated boundary when you are ready, with traceability and Part 11 intact, without re-platforming. Our thinking on that is in the AI-ready SCE ebook below.

Appsilon works with 8 of the top 10 pharma companies, has built open-source tools for life sciences since 2013, contributes to pharmaverse and is a Posit Certified Partner. The people on your calls are the engineers who design, build and validate these environments, not a sales team with a template.
A pre-commercial biotech went from fully CRO-dependent to an owned GxP environment supporting its BLA programme, built in six months in a greenfield context and presented at PHUSE US Connect 2026.
In 2026 a top-ten pharma company published the ten categories it tested in a four-week proof of concept before replacing its in-house SCE: 70 requirements, 33 of them critical, scored by 30 programmers and statisticians. Here is how we answer them. Mid-size biotechs now run the same process: written requirements, a formal RFP, a pilot with a short list of two. Bring your own list and we will score against it.
Read how Appsilon helped a top 50 pharmaceutical company design a custom system for analytics in R and Python, saving the client $930,000 annually.






Designs the target state with your team and challenges the assumptions under it, including ours.
Kubernetes, infrastructure as code, identity, storage and networking, in your cloud.
Package risk assessment, environment qualification and documented evidence for your QA and CSV owners.
SDTM, ADaM and TLF work in R and Python, so the environment is shaped by people who use one like it every day.
Learn how pharma companies are building validated, flexible platforms to support both regulatory submissions and modern analytics.

Data Engineering Lead
Top 10 Pharma Company
Associate Director
Top 50 Pharma Company
Human Resources People Partner
Top 10 Pharma Company
Most platform teams can build the infrastructure. What they tell us they cannot carry is the validation and the revalidation every time a component changes, and the platform-engineering bench to keep it that way. So the usual answer is neither build nor buy: you choose the components, we design, build and validate the integration in your cloud, and you own the result.
No. We integrate with the AWS or Azure account, identity provider, storage, Posit and SAS or Altair licences you already have, and with the systems around the environment: CRO data exchange, your clinical data repository, Pinnacle 21, TLF review tools and your version control. Rip-and-replace is how these programmes stall.
Yes. SAS code continues to execute in the environment, on SAS or on Altair SLC, so an auditor's request to rerun a historical analysis is answered from the same place. If a SAS performance fix cannot wait for the SCE, we design it so it lands inside the target environment instead of becoming a second migration.
Through a written, risk-based assessment: purpose, maintenance practice, community usage and test coverage, with the evidence filed. Packages are released on a published cadence, and study teams can request an out-of-cycle assessment against a submission timeline.
The discovery workshop is a fixed price. The build is scoped from the workshop's roadmap and costed increment by increment, with architecture and programme management as their own lines rather than buried in a day rate. Operations are an annual agreement sized to your environment. You get a ballpark for all three on the first call, so procurement is not the last surprise.
No. The full-environment engagements we have signed were with pre-commercial biotechs approaching a first submission, with biometrics teams of five to fifteen people and thin IT. That is where managed delivery matters most. Mid-size biotechs scaling their trial count run a formal selection, with written requirements and a pilot, and we take part in those on the buyer's own scorecard.
It can. Pharmacometrics tooling is regulated software with the same qualification needs as the programming environment, and the same case for one audit trail. We scope it as its own increment, with the previously validated tools migrated first.
Open a project template, pull the study data from the repository, work in RStudio, VS Code or SAS in the same workbench, submit a long job without a ticket, and commit to version control with the environment pinned. The evidence for the audit is produced by working, not by a second pass.
From custom dashboards and applications to AI-powered solutions and compliant computing environments, our engineers and infrastructure architects accelerate clinical development within fully validated, regulatory-compliant frameworks.